As­traZeneca strength­ens in­no­va­tion part­ner­ship in In­dia

BioSpectrum (India) - - COMPANY NEWS -

Lead­ing global sci­ence-led bio­phar­ma­ceu­ti­cal com­pany As­traZeneca has an­nounced its de­ci­sion of fur­ther in­vest­ing $ 90 mil­lion over the next 5 years in In­dia. The an­nounce­ment was made fol­low­ing a meet­ing be­tween the com­pany’s Ex­ec­u­tive Vice Pres­i­dent for In­ter­na­tional Re­gion – Leon Wang and Prime Min­is­ter of In­dia, Naren­dra Modi, dur­ing the lat­ter’s visit to Swe­den, where the two coun­tries signed a joint dec­la­ra­tion on in­no­va­tion part­ner­ship for a sus­tain­able fu­ture.

This in­vest­ment com­mit­ment will span across As­traZeneca’s di­verse foot­print in In­dia with an aim to strengthen its man­u­fac­tur­ing, clin­i­cal oper­a­tions, pa­tient safety & reg­u­la­tory sci­ence, IT ser­vices and com­mer­cial oper­a­tions. Fur­ther­more, this in­vest­ment will sup­port sci­en­tific data gen­er­a­tion, qual­ity man­u­fac­tur­ing, sci­ence tal­ent de­vel­op­ment and col­lab­o­ra­tive de­vel­op­ment of in­no­va­tive so­lu­tions to im­prove the stan­dard of care of non-com­mu­ni­ca­ble dis­eases in In­dia. The com­mit­ment also aligns closely with the In­dian govern­ment’s ini­tia­tives to cre­ate a stronger busi­ness, in­no­va­tion, and health­care en­vi­ron­ment such as “Skill In­dia”, “Na­tional Health Pol­icy” and “Ayush­man Bharat.”

As­traZeneca’s strat­egy in In­dia is to ad­dress the grow­ing bur­den of non-com­mu­ni­ca­ble dis­eases. The com­pany in­vests in many ini­tia­tives and pro­grammes such as the Young Health Pro­gramme, Early ac­tion in Di­a­betes & Healthy Lung for early ac­tion in aware­ness, pre­ven­tion, de­tec­tion and holis­tic man­age­ment of non-com­mu­ni­ca­ble dis­eases.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.